Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease

Quantum Blue® fCAL Citation:

Ferreiro-Iglesias, R., Barreiro-de Acosta, M., Lorenzo-Gonzalez, A. & Dominguez-Muñoz, J. E. Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients Under Maintenance With Anti-TNF Therapy: A Prospective Longitudinal Cohort Study. J. Clin. Gastroenterol. (2016) PMID:

remission, whereas concentrations >300 μg/g allow predicting relapse with a high probability at any time over the following 4 months.  PMID: 27984399. DOI:.10.1097/MCG.0000000000000774

Highlight from this Publication

“…time interval to the next FC measurement should be probably shorter than 4 months after a FC result of 130 to 300 mg/g…”

Read Citation
Quantum Blue® fCAL Assays are for Research Use Only. Not for use in diagnostic procedures in the US.
Quantum Blue® fCAL: Health Canada License:83477